Related Experiment Videos
Ligand-binding sites in human serum amyloid P component
N H Heegaard1, P M Heegaard, P Roepstorff
1Department of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark.
European Journal of Biochemistry
|August 1, 1996
Summary
Amyloid P component (AP) fragments were identified that bind to heparin. These findings offer insights into amyloid maintenance and potential therapeutic targets for diseases like Alzheimer's.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Science
Background:
- Amyloid P component (AP) is a glycoprotein found in serum and basement membranes.
- AP is present in amyloid deposits associated with Alzheimer's disease and Down's syndrome.
- AP's strong binding to glycosaminoglycans suggests a role in amyloid maintenance.
Purpose of the Study:
- To isolate and identify proteolytic fragments of AP responsible for heparin binding.
- To examine the structural requirements for the activity of these AP peptides.
- To explore potential applications in amyloid-targeted diagnostics and therapeutics.
Main Methods:
- Isolation and identification of AP proteolytic fragments.
- Solid-phase inhibition assays using synthetic peptides.
- Examination of Ca(2+)-dependent binding of AP to heparin.
Main Results:
- Two AP fragments with heparin-binding activity were isolated and identified.
- Neither fragment matched previously published heparin-binding sequences.
- Peptides AP-(192-203), AP-(27-38), and AP-(33-38) inhibited AP-heparin binding with IC50 values of 25, 10, and 2 μM, respectively.
Conclusions:
- Specific AP peptide sequences are responsible for heparin binding.
- Understanding these active peptides can aid in developing diagnostics and therapeutics for amyloid diseases.
- This research contributes to the understanding of amyloid P component's role in amyloidogenesis.